Related Experiment Video
Updated: Jan 26, 2026

A "Patient-Like" Orthotopic Syngeneic Mouse Model of Hepatocellular Carcinoma Metastasis
Published on: October 24, 2015
The effects of microRNA-1224-5p on hepatocellular carcinoma tumor endothelial cells
Chao Hu1, Xi Cheng1, Qi MingYu1
1Department of Abdominal Surgical Oncology, Zhejiang Cancer Hospital, Hangzhou, China.
Aim:
The aim of this study was to investigate the effect of microRNA-1224-5p (miR-1224-5p) on tumor endothelial cells (TECs) of human hepatocellular carcinoma (HCC).
Subjects And Methods:
Oligonucleotides were chemically synthesized and transfected into TECs using Lipofectamine 2000. TECs were divided into three groups, namely a control (CON) group without transfection, a negative control (NC) group transfected with negative control oligonucleotides and green fluorescent protein (GFP), and a micro-up (MU) group transfected with miR-1224-5p mimic and GFP. The expression of miR-1224-5p was quantified via quantitative reverse-transcription polymerase chain reaction (qRT-PCR). The proliferation of TECs was detected using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay, and the optical density value at 490 nm was measured after every 24 h. Apoptosis was detected via flow cytometry using a 7-aminoactinomycin/APC Annexin V kit. The migration and invasion of TECs were detected using transwell assay. The tube formation ability was evaluated using the tube formation assay.
Results:
Oligonucleotides were successfully transduced into TECs, and the expression of miR-1224-5p was specifically upregulated. The results of qRT-PCR analysis showed that the expression of miR-1224-5p was significantly upregulated in the MU group (2-ΔΔCt = 3.27 ± 0.15) than in the CON group (2-ΔΔCt = 1) and NC group (2-ΔΔCt = 1.08 ± 0.11) (P < 0.01). The results of MTT assay showed that the cell proliferation was significantly inhibited in the MU group at four time points than in the CON and NC groups (P < 0.01). Flow cytometry analysis revealed the significant increase in apoptosis of cells from the MU group (19.29% ± 0.95%) than those from the CON (8.73% ± 0.64%) and NC (9.51% ± 0.56%) (P < 0.01) groups. The migration ability was significantly inhibited in MU group (51.0 ± 3.6) as compared with CON (77.7 ± 2.5) and NC (79.2 ± 3.5) groups (P < 0.01). The invasion ability of TECs was significantly inhibited in MU group (9.8 ± 1.3) than in CON (15.8 ± 0.8) and NC (15.4 ± 0.9) groups (P < 0.01). The ability of tube formation of TECs was completely inhibited in MU group but remained unaffected in CON and NC groups.
Conclusions:
miR-1224-5p may serve as a potential tumor suppressor in HCC. Upregulation in miR-1224-5p expression may decrease proliferation, induce apoptosis, inhibit migration and invasion, and suppress tube formation in TECs of human HCC.
Insights
MicroRNA-1224-5p (miR-1224-5p) upregulation suppresses tumor endothelial cell growth, induces apoptosis, and inhibits migration and invasion in hepatocellular carcinoma (HCC). This suggests miR-1224-5p acts as a tumor suppressor in HCC.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Hepatocellular carcinoma (HCC) is a major global health concern.
- Tumor endothelial cells (TECs) play a critical role in HCC progression.
- MicroRNAs (miRNAs) are emerging as key regulators in cancer development.
Purpose of the Study:
- To investigate the functional role of microRNA-1224-5p (miR-1224-5p) in human HCC TECs.
- To determine the effect of miR-1224-5p upregulation on TEC proliferation, apoptosis, migration, invasion, and tube formation.
Main Methods:
- Chemical synthesis and transfection of miR-1224-5p mimics into TECs.
- Quantitative reverse-transcription polymerase chain reaction (qRT-PCR) for miR-1224-5p expression analysis.
- MTT assay for cell proliferation, flow cytometry for apoptosis, transwell assay for migration and invasion, and tube formation assay for angiogenesis assessment.
Main Results:
- miR-1224-5p was successfully upregulated in TECs.
- Upregulation of miR-1224-5p significantly inhibited TEC proliferation (P < 0.01).
- miR-1224-5p significantly increased TEC apoptosis (19.29% ± 0.95% vs. 8.73% ± 0.64%, P < 0.01), inhibited migration (51.0 ± 3.6 vs. 77.7 ± 2.5, P < 0.01), invasion (9.8 ± 1.3 vs. 15.8 ± 0.8, P < 0.01), and tube formation.
Conclusions:
- miR-1224-5p acts as a potential tumor suppressor in HCC.
- Upregulating miR-1224-5p expression in TECs can inhibit key processes of tumor growth and metastasis.
More Related Videos
10:18Exploring the Potential of Mesenchymal Stem Cell Sheet on The Development of Hepatocellular Carcinoma In Vivo
Published on: September 11, 2018
10:35Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
Published on: September 25, 2013
Related Concept Videos
MicroRNAs
MicroRNAs
Buffer Effectiveness
The buffer capacity is the amount of acid or base that can be added to a given volume...
Framing Effects
Biological Effects of Radiation
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...